Skip to content

A blood DNA methylation marker of cognitive ability is associated with six-year cognitive performance independent of blood Alzheimer's disease biomarkers.

Sep 2026 · The journals of gerontology. Series A, Biological sciences and medical sciences · 0 citations
Medicine

TL;DR

Preliminary evidence is provided that a cognition-trained DNAm signature captures variation in later cognitive performance not fully represented by baseline cognition or available ADRD blood biomarkers.

View source

Similar papers

Open access Apr 2026

Alzheimer’s Disease DNA Methylation Index (AD-DMI) and its Association with Late-Life Cognitive Function

The AD DNA Methylation Index (AD-DMI), a brain-derived risk index constructed from 100 CpG sites identified by elastic-net logistic regression of methylation data from postmortem dorsolateral prefrontal cortex tissue, provides a biologically grounded framework for linking disease-relevant methylation changes with cogni...

N. Jiakponnah, I. Biose, Tracy Fischer et al. · 1 citation
Open access Jul 2026

Comparative analyses of Alzheimer's disease blood biomarkers and cognitive domains

AD blood‐based biomarker–cognition associations were domain‐differentiated and context‐dependent: Concurrent associations did not reliably indicate associations with cognition 6 years later, and only p‐tau181 showed formal evidence of relative memory‐versus‐executive selectivity.

Deirdre M. O'Shea, James E. Galvin · 0 citations
Open access Sep 2026

Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease

In CSF-confirmed participants, age emerged as the most consistent predictor of plasma biomarker levels, particularly NFL and pTau181, which suggests that plasma biomarkers are influenced primarily by age and genetic background rather than by metabolic factors in this cohort.

Carolin I. Kurz, Marleen Taute, Paulina Tegethoff et al. · 0 citations
Open access Dec 2025

Developing Topics.

BACKGROUND Demonstrating the specificity of plasma biomarkers to AD-related neurodegeneration would add support to their prognostic and diagnostic clinical use. METHOD Participants from the Baltimore Longitudinal Study of Aging were cognitively unimpaired at the time of their plasma Aβ42/Aβ40, GFAP, NfL (Quanterix Ne...

Murat Bilgel, Ishaan Shah, Jasmine M. Cooper et al. · 0 citations
Open access Aug 2026

Association between Alzheimer’s disease-related genes and neurodegenerative blood-based biomarkers in Indian adults

Rare and common variants in AD- and neurodegenerative biomarker-associated genes with increased frequency in India compared to other populations may impact blood levels of neurodegenerative biomarkers in South Asians.

Hasan Abu-Amara, Wei Zhao, Zheng Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.